Chronic cardiac rehabilitation is a comprehensive and structured program designed to improve the health and well-being of individuals with chronic heart conditions. Tailored to the specific needs of patients with ongoing cardiac issues, this rehabilitation process focuses on enhancing cardiovascular fitness, managing symptoms, and promoting a heart-healthy lifestyle. Typically conducted under the supervision of healthcare professionals such as physiotherapists, exercise physiologists, and nurses, chronic cardiac rehabilitation includes a combination of exercise training, education, and counseling. Patients engage in carefully monitored physical activities to strengthen their heart muscles, improve endurance, and enhance overall cardiovascular function. Educational components cover topics such as heart-healthy nutrition, stress management, medication adherence, and risk factor modification. This holistic approach aims to empower individuals with chronic cardiac conditions to lead active and fulfilling lives while minimizing the risk of future cardiovascular events. Chronic cardiac rehabilitation plays a crucial role in not only managing existing heart conditions but also in preventing further complications, ultimately contributing to a higher quality of life for those undergoing the program.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India